MEX Equity Snapshot
VRTX Weekly Equity Report
Vertex Pharmaceuticals Incorporated
What the company does
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; …
What the weekly tape is saying
VRTX closed the latest completed week at 7,592 MXN. The 4-week return is -2.3% and the 12-week return is -7.2%. Trend Signal is inactive, Market Dynamics is -0.88. Setup signature: Balanced read with a 42/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 7,925 MXN
- Vs Trend Line
- -4.2%
- Fair Value
- 7,927 MXN
- Vs Fair Value
- -4.2%
- 52W High
- 8,889 MXN
- 52W Low
- 6,800 MXN
- Drawdown
- -14.6%
- Range Position
- 37.9%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 10
- 52W Active Breadth
- 19.2%
- Sector Scope
- MX Healthcare
- Sector Rank
- 12 of 78
- Sector Percentile
- 85.7%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
MX Healthcare
- Tracked Peers
- 78
- 4W Rank
- 56 of 78
- Avg 1W
- -0.7%
- Avg 4W
- 0.4%
- Trend Breadth
- 19.2%
- Positive MD
- 29.5%
MX Biotechnology
- Tracked Peers
- 19
- 4W Rank
- 10 of 19
- Avg 1W
- -2.0%
- Avg 4W
- -7.2%
- Trend Breadth
- 15.8%
- Positive RS
- 10.5%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.88
- 4W MD Change
- 23.1%
- Relative Strength
- -9.75
- 4W RS Change
- -0.0%
- Expectation
- Negative
- Probability
- 43.17%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 642
- 13W Average
- 300
- 52W Average
- 686
- Vs 13W
- 2.1x
- Vs 52W
- 0.9x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 2.8%
- 52W Volatility
- 3.7%
- Upside Weeks
- 21
- Downside Weeks
- 23
- Downside Breadth
- 44.2%
- Avg Gain / Loss
- 2.7% / -2.8%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- MEX
- Country
- MX
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- MXN
- Market Cap
- 1954.3B
Opportunity signals
- Volume is elevated versus the 13-week average, confirming attention.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 7,592 MXN | 2.2% | 7,925 MXN | 7,927 MXN | -0.88 | -9.75 | 642 | Off |
| 5 Jun 2026 | 7,426 MXN | -3.6% | 7,942 MXN | 7,917 MXN | -0.93 | -9.83 | 84 | Off |
| 29 May 2026 | 7,700 MXN | 2.2% | 7,953 MXN | 7,905 MXN | -0.98 | -10.37 | 53 | Off |
| 22 May 2026 | 7,535 MXN | -3.0% | 7,956 MXN | 7,892 MXN | -1.08 | -12.50 | 1.1K | Off |
| 15 May 2026 | 7,770 MXN | 6.0% | 7,965 MXN | 7,881 MXN | -1.14 | -9.75 | 25 | Off |
| 8 May 2026 | 7,333 MXN | -2.2% | 7,957 MXN | 7,870 MXN | -1.13 | -17.52 | 47 | Off |
| 1 May 2026 | 7,501 MXN | -1.4% | 7,967 MXN | 7,862 MXN | -1.05 | -13.70 | 119 | Off |
| 24 Apr 2026 | 7,610 MXN | 0.1% | 7,965 MXN | 7,854 MXN | -0.86 | -14.91 | 22 | Off |
| 17 Apr 2026 | 7,602 MXN | -0.6% | 7,945 MXN | 7,844 MXN | -0.64 | -16.41 | 1.1K | Off |
| 10 Apr 2026 | 7,648 MXN | -4.4% | 7,928 MXN | 7,833 MXN | -0.35 | -17.13 | 121 | On |
| 3 Apr 2026 | 8,000 MXN | -0.3% | 7,916 MXN | 7,823 MXN | 0.13 | -13.95 | 8 | On |
| 27 Mar 2026 | 8,022 MXN | -1.9% | 7,898 MXN | 7,808 MXN | 0.33 | -10.76 | 155 | On |
| 20 Mar 2026 | 8,177 MXN | -3.1% | 7,875 MXN | 7,793 MXN | 0.45 | -6.34 | 451 | On |
| 13 Mar 2026 | 8,441 MXN | 0.7% | 7,849 MXN | 7,777 MXN | 0.45 | -6.40 | 2.1K | On |